Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations.
about
Resistance of dialyzed patients to erythropoietin.Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease.An emerging need for developing new models for myocardial infarction as a chronic complex disease: lessons learnt from animal vs. human studies on cardioprotective effects of Erythropoietin in reperfused myocardium.Anemia in chronic kidney disease.The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
P2860
Resistance to erythropoietin-stimulating agents: etiology, evaluation, and therapeutic considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Resistance to erythropoietin-s ...... nd therapeutic considerations.
@en
Resistance to erythropoietin-s ...... nd therapeutic considerations.
@nl
type
label
Resistance to erythropoietin-s ...... nd therapeutic considerations.
@en
Resistance to erythropoietin-s ...... nd therapeutic considerations.
@nl
prefLabel
Resistance to erythropoietin-s ...... nd therapeutic considerations.
@en
Resistance to erythropoietin-s ...... nd therapeutic considerations.
@nl
P2860
P1433
P1476
Resistance to erythropoietin-s ...... nd therapeutic considerations.
@en
P2093
Oluwatoyin Bamgbola
P2860
P2888
P304
P356
10.1007/S00467-011-1839-4
P577
2011-03-20T00:00:00Z